A selective human β3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2387-2393

  Fisher, Michael H ^a   Amend, Angela M ^a   Bach, Thomas J ^a   Barker, Jeanne M ^a   Brady, Edward J ^a   Candelore, Mari R ^a   Carroll, Dayna ^a   Cascieri, Margaret A ^a   Chiu, Shuet Hing Lee ^a   Deng, Liping ^a   Forrest, Michael J ^a   Hegarty Friscino, Bonnie ^a   Guan, Xiao Ming ^a   Hom, Gary J ^a   Hutchins, Jennifer E ^a   Kelly, Linda J ^a   Mathvink, Robert J ^a   Metzger, Joseph M ^a   Miller, Randall R ^a   Ok, Hyun O ^a   Parmee, Emma R ^a   Saperstein, Richard ^a   Strader, Catherine D ^a   Stearns, Ralph A ^a   Marie Thompson, G ^a   Tota, Laurie ^a   Vicario, Pasquale P ^a   Weber, Ann E ^a   Woods, John W ^a   Wyvratt, Matthew J ^a   Zafian, Peter T ^a   Euan MacIntyre, D ^a   more..

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Brown fat; Energy metabolism; Lipolysis; Obesity; Uncoupling protein

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BENZENESULFONAMIDE DERIVATIVE; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; HEXYLUREA; ISOPRENALINE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; L 755507; PROPANOLAMINE DERIVATIVE; SULFONAMIDE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; ENERGY EXPENDITURE; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIPOLYSIS; MALE; METABOLIC RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR DENSITY; RESPIRATORY QUOTIENT; WEIGHT REDUCTION; ANIMAL; CHO CELL; DRUG EFFECT; FEMALE; HAMSTER; MACACA;

ADIPOSE TISSUE, BROWN; ADRENERGIC BETA-AGONISTS; ANIMALS; CHO CELLS; CRICETINAE; FEMALE; HEART RATE; HUMANS; LIPOLYSIS; MACACA MULATTA; MALE; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; SULFONAMIDES;

EID: 0032081279     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2496     Document Type: Article

References (29)

1. Leibel, R.L., M. Rosenbaum, and J. Hirsch. 1995. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332:621-628.
2. Arch, J.R.S., A.T. Ainsworth, M.A. Cawthorne, V. Piercy, M.V. Sennitt, V.E. Thody, C. Wilson, and S. Wilson. 1984. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 309:163-165.
3. Lowell, B.B., and J.S. Flier. 1997. Brown adipose tissue, beta3-adrenergic receptors, and obesity. Annu. Rev. Med. 48:307-316.
4. Garlid, K.D., D.E. Orosz, M. Modriansky, S. Vassanelli, and P. Jezek. 1996. On the mechanism of fatty acid-induced proton transport by mitochondrial uncoupling protein. J. Biol. Chem. 271:2615-2620.
5. Holloway, B.R. 1989. Selective β-agonists of brown fat and thermogenesis. In Hormones, Thermogenesis and Obesity. H.A. Lardy and F.W. Stratman, editors. Elsevier, New York. 477-484.
6. Bloom, J.D., M.D. Dutia, B.D. Johnson, A. Wissner, M.G. Burns, E.E. Largis, J.A. Dolan, and T.H. Claus. 1992. Disodium (R,R,)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3-benzodioxole- 2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta-3 receptors. A promising antidiabetic and antiobesity agent. J. Med. Chem. 35: 3081-3084.
7. Croci, T., R. Cecchi, A. Tarantino, G. Aureggi, A. Bianchetti, R. Boigegrain, and L. Manara. 1988. Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents. Pharmacol. Res. Commun. 20:147-151.
8. Arch, J.R.S., M.A. Cawthorne, K.A. Coney, B.A. Gusterson, V. Piercy, M.V. Sennitt, S.A. Smith, J. Wallace, and S. Wilson. 1991. β-Adrenoceptor-mediated control of thermogenesis, body composition and glucose homeostasis. In Obesity and Cachexia. N.J. Rothwell and M.J. Stock, editors. John Wiley & Sons, Ltd., New York. 242-268.
9. Connacher, A.A., R.T. Jung, and P.E.G. Mitchell. 1988. Weight loss in obese subjects on a restricted diet given BRL26830A. a new atypical beta-adrenoceptor agonist. Br. Med. J. Clin. Res. Ed. 296:1217-1220.
10. Wheeldon, N.M., D.G. McDevitt, and B.J. Lipworth. 1994. Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man. Br. J. Clin. Pharmacol. 37:363-369.
11. Emorine, L.J., S. Marullo, M.M. Breind-Sutren, G. Patey, K. Tate, C. Delavier-Kluthko, and A.D. Strosberg. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science. 245:1118-1121.
12. Granneman, J.G., K.M. Lahners, and D.D. Rao. 1992. Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block. Mol. Pharmacol. 42:964-970.
13. Liggett, S.B. 1992. Functional properties of the rat and human beta 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol. Pharmacol. 42:634-637.
14. Meyers, D.S., S. Skwish, K.E.J. Dickinson, B. Kienzle, and C.M. Arbeeny. 1997. Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys. J. Clin. Endocrinol. Metab. 82:395-401.
15. Enocksson, S., M. Shimizu, F. Lonnqvist, J. Nordenstrom, and P. Arner. 1995. Demonstration of an in vivo functional beta 3-adrenoceptor in man. J. Clin. Invest. 95:2239-2245.
16. Wilson, S., J.K. Chambers, J.E. Park, A. Ladurner, D.W. Cronk, C.G. Chapman, H. Kallender, M.J. Browne, G.J. Murphy, and P.W. Young. 1996. Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay. J. Pharmacol. Exp. Ther. 279:214-221.
17. Frielle, T., S. Collins, K.W. Daniel, M.G. Caron, R.J. Lefkowitz, and B.K. Kobilka. 1987. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 84:7920-7924.
18. Kobilka, B.K., R.A. Dixon, T. Frielle, H.G. Dohlman, M.A. Bolanoski, I.S. Sigal, T.L. Yan-Feng, U. Francke, M.G. Caron, and R.J. Lefkowitz. 1987. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 84:46-50.
19. Rodbell, M. 1964. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239:375-380.
20. Lonnqvist, F., S. Krief, A.D. Strosberg, B. Nyberg, J. Emorine, and P. Arner. 1993. Evidence for a functional beta 3-adrenoceptor in man. Br. J. Pharmacol. 110:929-936.
21. Tavernier, G., P. Barbe, J. Galitzky, M. Berlan, D. Caput, M. Lafontan, and D. Langin. 1996. Expression of beta 3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J. Lipid Res. 37:87-97.
22. Revelli, J.-P., P. Muzzin, A. Paolini, M. Moinat, and J.-P. Giacobino. 1993. Expression of the beta 3-adrenergic receptor in human white adipose tissue. J. Mol. Endocrinol. 10:193-197.
23. Fleury, C., M. Neverova, S. Collins, S. Raimbault, O. Champigny, C. Levi-Meyrueis, F. Bouillaud, M.F. Seldin, R.S. Surwit, D. Ricquier, and C.H. Warden. 1997. Uncoupling protein-2: a novel gene linked to obesity and hyper-insulinemia. Nat. Genet. 15:269-272.
24. Lean, M.E.J. 1992. Evidence for brown adipose tissue in humans. In Obesity. P. Bjorntorp and B.N. Brodoff, editors. J.B. Lippincott Co., Philadelphia, 117-129.
25. Gong, D.-W., Y. He, M. Karas, and M. Reitman. 1997. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, β3-adrenergic agonists, and leptin. J. Biol. Chem. 272:24129-24132.
26. Grujic, D., V.S. Susulic, M.-E. Harper, J. Himms-Hagen, B.A. Cunningham, B.E. Corkey, and B.B. Lowell. 1997. β3-Adrenergic receptors on white and brown adipocytes mediate β3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. J. Biol. Chem. 272:17686-17693.
27. Champigny, O., D. Ricquier, O. Blondel, R.M. Mayers, M.G. Briscoe, and B.R. Holloway. 1991. β3-Adrenergic receptor stimulation restores message and expression of brown-fat mitochondrial uncoupling protein in adult dogs. Proc. Natl. Acad. Sci. USA. 88:10774-10777.
28. Bousquet-Melou, A., J. Galitzky, C. Carpene, M. Lafontan, and M. Berlan. 1994. Beta-adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals. Am. J. Physiol. 267:115-123.
29. Cannon, B., A. Jacobsson, S. Rehnmark, and J. Nedergaard. 1996. Signal transduction in brown adipose tissue recruitment: noradrenaline and beyond. Int. J. Obesity. 20:36-42.